Strategic collaboration combines human microphysiological systems, biology-driven AI/ML platforms and orbital research to generate high-value clinical surrogate insights
HYDERABAD, India and FOETZ, Luxembourg, x August 2026 – Transcell Biologics Private Limited (“Transcell Biologics”), a pioneer in offering non-animal New Approach Methodologies (“NAMs”) that de-risk therapeutic development and reduce animal testing, and Space Cargo Unlimited, a commercial space company providing orbital research and logistics infrastructure for the life sciences industry, today announced a strategic collaboration to investigate how microgravity can improve drug and vaccine development workflows by generating more predictive human-relevant mechanistic evidence.
The collaboration will initially focus on applications across oncology, immunology, neurodegenerative disease, metabolic disorders, and anti-aging, where improving the prediction of human outcomes remains a significant challenge.
——————————————————————
About Transcell Biologics:
Tran-Scell Biologics Private Limited is an India-based category defining biotechnology company building the new operating system for human biology. The company offers deployable industrialized non-animal NAMs to the global pharma industry. Its flagship productized offering DART (Digital Animal Replacement Technology) leverages a well-characterized portfolio of human microphysiological systems and AI/ML tools transforming drug and vaccine discovery and developmental workflows.
About Space Cargo Unlimited
Space Cargo Unlimited is a Luxembourg-based space company pioneering commercial in-space manufacturing. Founded to unlock the industrial potential of microgravity, Space Cargo Unlimited develops technologies and mission services that enable organizations to research, develop and manufacture high-value products in space.
Its flagship BentoBox platform provides a standardized, autonomous laboratory for in-space experimentation and production, supported by end-to-end mission services from payload preparation and integration through launch and in-orbit operations. By deploying its standardized platform across multiple space vehicles, Space Cargo Unlimited is creating a scalable, fleet-based model for commercial in-space manufacturing and helping accelerate the commercialization of the low Earth orbit economy.
Media Contacts:
Abhishek Akshantala
abhishek@tran-scell.com
https://transcellbiologics.com/
Francesca Byrne at AstroAgency
francesca@astroagency.co.uk
https://astroagency.co.uk/
